November 4
Britain’s medicines regulator said on Thursday it had approved a COVID-19 antiviral oral pill jointly developed by Merck and Ridgeback Biotherapeutics, the first country to clear a potentially game-changing therapy for the illness.- Reuters
(The article is generated from The Tribune via feeds, The Chenab Times staff didn’t wrote this news.)
The Chenab Times News Desk